Drug name - Triesence

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8211880 NOVARTIS Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection Mar, 2029

(6 years from now)

US8128960 NOVARTIS Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection Dec, 2029

(7 years from now)

Drugs and Companies using TRIAMCINOLONE ACETONIDE ingredient

Treatment: Visualization during vitrectomy procedures; treatment of ophthalmic disorders

Dosage: INJECTABLE;INTRAVITREAL

More Information on Dosage
Strength Dosage Availability
40MG/ML (40MG/ML) INJECTABLE;INTRAVITREAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.